Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Inotiv, Inc. (NOTV)

NASDAQ

$--

(--)

Market Closed

Inotiv, Inc. (NOTV) Live Price Chart

Last updated: ⁦2026-09-06 08:56:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Inotiv, Inc. (NOTV) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Inotiv, Inc. (NOTV) Latest Closing Stock Price

Inotiv, Inc. (NOTV) last closed at $-- as of --, -- from the previous close of $--.

During the latest regular trading session, NOTV traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.

Inotiv, Inc. (NOTV) 7-Day Stock Price Change

Over the past seven days, Inotiv, Inc. (NOTV) moved from $0.28 to $0.08, representing a decline of 71.87% ($0.20).

The stock traded between $0.08 and $0.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 171.67 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Inotiv, Inc. (NOTV)?

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Inotiv, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	2046
Exchange	NASDAQ
Company Website	https://www.inotivco.com

How to Buy Inotiv, Inc. (NOTV) Stock on MEXC

Eligible investors can buy real shares of Inotiv, Inc. (NOTV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NOTV and Place Your Order

Open the RealStocks trading page and search for NOTV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Inotiv, Inc. (NOTV) share price today?

Inotiv, Inc. (NOTV) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is NOTV stock going up or down today?

As of --, NOTV is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is NOTV pre-market price?

As of --, NOTV is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NOTV after-hours price?

As of --, NOTV is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is NOTV stock trading now?

NOTV trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NOTV sit relative to its 52-week high and low?

Over the past 52 weeks, NOTV has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Inotiv, Inc. in?

Inotiv, Inc. (NOTV) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Inotiv, Inc.'s market capitalisation and where is it listed?

Inotiv, Inc. is listed on the NASDAQ exchange with a market capitalisation of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NOTV valued in terms of P/E ratio and EPS?

NOTV trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Inotiv, Inc. pay a dividend?

Inotiv, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.